Our lateral flow assay and reader contract services team has significant experience of working with customers across a range of sectors including healthcare, animal health and agriculture and food testing.
Based on our proven technology we offer our academic and commercial partners a complete integrated solution for the development and manufacturing of lateral flow products and reader systems.
Whether customers are looking to convert an ELISA assay into LFD, or are looking to apply a fully validated reagent to LFD, Abingdon Health uses a comprehensive step-by-step approach to assay development. Accompanying this is our ability to combine lateral flow rapid tests with reader systems in order to provide fully quantitative assays.
We also offer customisable OEM reader solutions for lateral flow rapid testing using state-of-the-art technology taken from our CE marked and FDA registered touchscreen reader, ADxLR5®.
Abingdon Health has ISO 13485:2016 and ISO 9001:2015 certification for the development and manufacture of lateral flow immunoassay diagnostics.
In addition, Abingdon Health’s manufacturing facilities are GMP compliant, with the U.S. Food and Drug Administration (FDA), for the design, development and manufacture of LFD, and device readers for in vitro diagnostic medical use.
What is a lateral flow immunoassay?
The following article describes what a lateral flow immunoassay is used for. […]Read More
Lateral Flow Manufacturing
Click to view our development and manufacturing capabilities for rapid lateral flow assays and reader systems.Read More
A recent study used Abingdon Health’s Seralite®-FLC #ELISA to assess the impact of long duration spaceflight on ast… https://t.co/aITphdnAqP
22 June 2018
© Abingdon Health 2018